OH SB207

Prohibits health insurers, health insuring corporations, and pharmacy benefit managers from setting or altering coverage terms based on the availability or amount of financial assistance (such as manufacturer copay cards) for prescription drugs

Requires insurers to count all payments toward a patient's cost-sharing obligations for prescription drugs, including amounts paid by third parties on the patient's behalf, when calculating progress toward deductibles and out-of-pocket maximums

Exempts brand-name drugs with generic equivalents from the third-party payment counting requirement unless the prescriber determines the brand drug is medically necessary

Applies to health benefit plans delivered, issued, modified, or renewed on or after January 1, 2027, and requires annual compliance certification from insurers and pharmacy benefit managers to the Superintendent of Insurance by March 1 each year

Maintains existing federal cost-sharing limits under the Affordable Care Act (42 U.S.C. 18022) and preserves health savings account eligibility by delaying certain requirements until minimum deductibles are met for high-deductible plans